Progyny (PGNY) Competitors $21.55 -0.14 (-0.65%) As of 06/12/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PGNY vs. OPCH, GH, RDNT, BTSG, SHC, SGRY, PRVA, CON, LFST, and WGSShould you be buying Progyny stock or one of its competitors? The main competitors of Progyny include Option Care Health (OPCH), Guardant Health (GH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Surgery Partners (SGRY), Privia Health Group (PRVA), Concentra Group Holdings Parent (CON), LifeStance Health Group (LFST), and GeneDx (WGS). These companies are all part of the "healthcare" industry. Progyny vs. Its Competitors Option Care Health Guardant Health RadNet BrightSpring Health Services Sotera Health Surgery Partners Privia Health Group Concentra Group Holdings Parent LifeStance Health Group GeneDx Progyny (NASDAQ:PGNY) and Option Care Health (NASDAQ:OPCH) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, earnings, media sentiment, valuation, institutional ownership, dividends, community ranking, analyst recommendations and profitability. Do analysts prefer PGNY or OPCH? Progyny presently has a consensus price target of $23.45, suggesting a potential upside of 8.84%. Option Care Health has a consensus price target of $35.50, suggesting a potential upside of 11.39%. Given Option Care Health's stronger consensus rating and higher possible upside, analysts clearly believe Option Care Health is more favorable than Progyny.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Progyny 0 Sell rating(s) 7 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.42Option Care Health 0 Sell rating(s) 1 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.88 Which has more volatility & risk, PGNY or OPCH? Progyny has a beta of 1.32, indicating that its stock price is 32% more volatile than the S&P 500. Comparatively, Option Care Health has a beta of 0.74, indicating that its stock price is 26% less volatile than the S&P 500. Does the media refer more to PGNY or OPCH? In the previous week, Progyny had 3 more articles in the media than Option Care Health. MarketBeat recorded 9 mentions for Progyny and 6 mentions for Option Care Health. Option Care Health's average media sentiment score of 1.74 beat Progyny's score of 0.68 indicating that Option Care Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Progyny 3 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Option Care Health 4 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Does the MarketBeat Community prefer PGNY or OPCH? Progyny received 38 more outperform votes than Option Care Health when rated by MarketBeat users. Likewise, 70.34% of users gave Progyny an outperform vote while only 64.00% of users gave Option Care Health an outperform vote. CompanyUnderperformOutperformProgynyOutperform Votes10270.34% Underperform Votes4329.66% Option Care HealthOutperform Votes6464.00% Underperform Votes3636.00% Do institutionals & insiders have more ownership in PGNY or OPCH? 94.9% of Progyny shares are owned by institutional investors. Comparatively, 98.1% of Option Care Health shares are owned by institutional investors. 9.4% of Progyny shares are owned by company insiders. Comparatively, 0.6% of Option Care Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Which has higher valuation & earnings, PGNY or OPCH? Option Care Health has higher revenue and earnings than Progyny. Option Care Health is trading at a lower price-to-earnings ratio than Progyny, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioProgyny$1.21B1.52$62.04M$0.5737.81Option Care Health$5.19B1.01$267.09M$1.2425.70 Is PGNY or OPCH more profitable? Progyny has a net margin of 5.03% compared to Option Care Health's net margin of 4.37%. Option Care Health's return on equity of 15.30% beat Progyny's return on equity.Company Net Margins Return on Equity Return on Assets Progyny5.03% 11.36% 7.87% Option Care Health 4.37%15.30%6.57% SummaryProgyny and Option Care Health tied by winning 9 of the 18 factors compared between the two stocks. Get Progyny News Delivered to You Automatically Sign up to receive the latest news and ratings for PGNY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PGNY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PGNY vs. The Competition Export to ExcelMetricProgynyhealth & allied services, not elsewhere classified IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.86B$2.01B$5.61B$8.62BDividend YieldN/A7.21%5.28%4.17%P/E Ratio37.1616.1727.1719.96Price / Sales1.524.52410.96157.63Price / Cash35.589.3238.2534.64Price / Book3.733.967.064.69Net Income$62.04M$87.49M$3.23B$248.14M7 Day Performance-0.60%0.67%0.77%0.95%1 Month Performance-0.60%1.43%9.67%5.74%1 Year Performance-21.15%-17.97%32.02%14.73% Progyny Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PGNYProgyny1.1252 of 5 stars$21.55-0.6%$23.45+8.8%-22.3%$1.86B$1.21B37.16310OPCHOption Care Health4.0145 of 5 stars$31.86-2.5%$35.50+11.4%+13.2%$5.22B$5.19B26.775,600Positive NewsGHGuardant Health3.7951 of 5 stars$42.10+3.6%$52.32+24.3%+54.0%$5.22B$774.00M-11.831,790RDNTRadNet3.5979 of 5 stars$58.26+1.3%$69.75+19.7%-8.4%$4.37B$1.87B-832.178,970Positive NewsBTSGBrightSpring Health Services0.7692 of 5 stars$23.93+0.5%$23.56-1.6%+99.3%$4.17B$11.86B-92.0435,000SHCSotera Health3.4643 of 5 stars$12.19-0.4%$15.80+29.6%-2.0%$3.46B$1.11B48.763,000Positive NewsSGRYSurgery Partners2.8153 of 5 stars$23.39-0.9%$33.56+43.5%-13.3%$3.00B$3.17B-48.7312,200PRVAPrivia Health Group3.6913 of 5 stars$22.83+0.3%$27.77+21.6%+29.7%$2.78B$1.80B228.32810Positive NewsCONConcentra Group Holdings ParentN/A$21.44-0.9%$28.50+32.9%N/A$2.73B$1.93B16.0011,000Positive NewsLFSTLifeStance Health Group2.6374 of 5 stars$5.88-1.0%$8.50+44.6%-0.9%$2.29B$1.28B-22.626,640WGSGeneDx3.7822 of 5 stars$74.13+4.1%$86.75+17.0%+143.3%$2.12B$330.14M-37.821,200 Related Companies and Tools Related Companies Option Care Health Alternatives Guardant Health Alternatives RadNet Alternatives BrightSpring Health Services Alternatives Sotera Health Alternatives Surgery Partners Alternatives Privia Health Group Alternatives Concentra Group Holdings Parent Alternatives LifeStance Health Group Alternatives GeneDx Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PGNY) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Progyny, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Progyny With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.